AlphaCrest Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-7,416
| Closed | -$610K | – | 1402 |
|
|
2022
Q1 | $610K | Buy |
7,416
+2,011
| +37% | +$165K | 0.03% | 801 |
|
|
2021
Q4 | $793K | Buy |
+5,405
| New | +$793K | 0.03% | 910 |
|
|
2021
Q3 | – | Sell |
-3,800
| Closed | -$614K | – | 1417 |
|
|
2021
Q2 | $614K | Sell |
3,800
-1,284
| -25% | -$207K | 0.03% | 881 |
|
|
2021
Q1 | $871K | Buy |
5,084
+3,284
| +182% | +$563K | 0.05% | 555 |
|
|
2020
Q4 | $395K | Buy |
+1,800
| New | +$395K | 0.03% | 793 |
|
|
2020
Q2 | – | Sell |
-3,300
| Closed | -$254K | – | 1173 |
|
|
2020
Q1 | $254K | Buy |
+3,300
| New | +$254K | 0.03% | 859 |
|